TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: CVD risk reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total cholesterol reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean triglycerides value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean cholesterol value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Progression of diabetic retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Mean duration of catheterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of catheter sepsis
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of mechanical complications
Endpoint domain: Adverse events/effects
Primary endpoint: Interleukin 8 release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Complement activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: puncture time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: fluoroscopy frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time taken for placement of high thoracic epidural anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of attempts for placement of high thoracic epidural anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change from baseline in HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial plasma glucose (PPG) control after 1 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postmeal hypoglycemia rates (0-2 h)
Endpoint domain: Adverse events/effects
Primary endpoint: Tear Evaporation Rate (TER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Noninvasive Tear Breakup Time (NITBUT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Habituation speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of pre-eclampsia or gestational hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: remission rate after 6 months
Endpoint domain: Mortality/survival
Primary endpoint: remission rate after 12 months
Endpoint domain: Mortality/survival
Primary endpoint: arousal index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: CPAP compliance rate
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Bodily pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Difference in a* value between arm positions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time to spontaneous eye opening after end of surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postanesthetic recovery scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biliary stent patency time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Discordance in LV systolic function measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical response (ACR20, DAS28-CRP, PASI75)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic progression (mean change in PsA-modified SHS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean increase in blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean reduction in FFA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean increase in intact proinsulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Maternal heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Volume of bacterial organisms cultured
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of current regular drinkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion engaging in heavy episodic drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Access time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: First attempt cannulation success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Knowledge of HBV transmission modes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: >or=50% response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall enucleation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Remnant growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appearance of new nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Overall reoperation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: tissue-type plasminogen activator (tPA) antigen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: von Willebrand factor (vWF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in plasma fatty acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: IDL-A levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of cases of pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted annualized relapse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of new/newly enlarging T2 hyperintense lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean annualized change in brain volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TUG test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wheezing remission time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cough remission time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Eradication of gastric varices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of sclerosant used
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endoscopic grade of esophageal varices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioavailability of WBB anthocyanins and 3-CGA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAC-SYM severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Maximum blood glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean glycemia during feeding periods
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urinary levels of CTX‐II
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Serum levels of HA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Serum levels of MMP‐3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Serum levels of MMP‐13
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Isokinetic strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of mild corneal epithelial injury at 1 hour after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of iron deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Edinburgh Postnatal Depression Scale (EPDS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of e-cigarette use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma melatonin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate after implementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: own felt safety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: task efficiency
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Seroconversion rate for JENVAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroprotection rate for JENVAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean titers for JENVAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: patients' latent satisfaction level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Renal Resistive Index (RI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in cancellous spine BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate (> or = 50% improvement)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of progressive disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forearm blood flow (FBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: completion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stopping time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of stops
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in capsaicin-induced hyperalgesia area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative 1st-hour serum AST and ALT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reticulocyte rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Average time to successfully insert the BIG's needle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of intraosseous insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of IRDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Perinatal morbidity and mortality
Endpoint domain: Mortality/survival
Primary endpoint: Supervisor knowledge on IPV
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Workplace climate towards IPV
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Availability of IPV information and postings
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: EMD 87 580 clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: plasma concentrations of EMD 87 580 (AUC0-infinity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal arterial PO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Umbilical venous PO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentrations of lipid peroxides
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate of hepatitis B e antigen and hepatitis B virus DNA clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of homocysteine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of counseling
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Choice of PPIUD
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: vessel curvature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of bends/lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vessel angulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total dosages of lidocaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentrations of lidocaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in density of microfilariae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eye movement behavior towards pain-related images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of pulmonary complications
Endpoint domain: Adverse events/effects
Primary endpoint: length of stay in the postanesthesia care unit
Endpoint domain: Resource use
Primary endpoint: stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight bearing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fatal and nonfatal myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: class IV heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: vertical relative attachment gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographic infrabony defect fill
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of VTE without pulmonary embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Slight bleeding complications
Endpoint domain: Adverse events/effects
Primary endpoint: Patient acceptance of treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cognitive decline after operation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: CSF enzyme concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Positive banana skin-prick test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Symptoms from eating or handling bananas
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of lateral angulation after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: serum PCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Good recovery at discharge
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Complications (wound infection, tension pneumocephalus)
Endpoint domain: Adverse events/effects
Primary endpoint: Peak eosinophil counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Understanding of risk communication messages
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvement in classroom delivery
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Improvement in teaching evaluation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Improvement in planning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Eosinophil count in esophageal epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Dysphagia scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 5-year cumulative incidence of isolated LRR
Endpoint domain: Mortality/survival
Primary endpoint: 5-year cumulative incidence of LRR as any component of failure
Endpoint domain: Mortality/survival
Primary endpoint: 5-year nodal relapse-free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: 5-year distant metastases-free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: 5-year disease-specific survival rates
Endpoint domain: Mortality/survival
Primary endpoint: verbal memory (delayed story recall)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Concentration of serum vitamin B12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of serum folate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Redox plasma aminothiol status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Baroreflex Sensitivity (BRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visual analog pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: short form-36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in rhinoconjunctivitis symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in medication score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in well days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: FMS™ composite scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AMH below the level of detection for prediction of POI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidence of respiratory symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adherence to dosing regimen and timing of AL administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean left atrium instrumentation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Vasoconstriction response to ACh
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Need for redilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Freedom from dysphagia
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ability to accept a normal diet
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SF AAROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF AROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sunitinib trough concentrations (C trough)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: no vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Constipation requiring specific treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Symptomatic benefit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Body Composition Improvement Index (BCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body fat loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in BIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excess mortality
Endpoint domain: Mortality/survival
Primary endpoint: Serum estradiol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Suppression of follicle-stimulating hormone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Leak pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of intraoperative dislodgment
Endpoint domain: Adverse events/effects
Primary endpoint: incremental cost-effectiveness ratio per life-year gained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: plasma tolvaptan C(max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(∞) geometric mean ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fluid balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-point decrease in the NIH-CPSI total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reinfarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pulmonary function improvement (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hospitalization rate
Endpoint domain: Adverse events/effects
Primary endpoint: Local Tumor Control (LTC)
Endpoint domain: Mortality/survival